Please enable JavaScript or talk to your local administrator to get JavaScript enabled.

Project

The efficacy of renin-angiotensin system blockade for upper tract urothelial carcinoma

Funder: Japan Society for the Promotion of Science

Funding period
JPY 4.2 M
USD 46 K
Funding amount
Abstract
Using a multi-institutional and retrospective cohort of patients with upper tract urothelial carcinoma (UTUC) in Japan, we found that the absence of renin-angiotensin system (RAS) inhibitors was significantly associated with disease recurrence following radical nephroureterectomy independent of other clinicopathological parameter, suggesting RAS inhibition might be effective to prevent subsequent relapsing in UTUC. Moreover, immunohistochemical analysis in surgical specimens revealed that the microvessel density in tumors was significantly associated with oncological outcome in UTUC patients, suggesting the importance of its upper modulator of RAS regulation in UTUC.
Similar projects All >
Sorted by: Start Date
Project list item
Clonal evolution and molecular stratification of urothelial carcinoma in situ of the urinary bladder

German Research Foundation to Stefan Garczyk, Nadine Gaisa

 
2019 -
Project list item
Upper tract urothelial carcinoma is non-basal and T-cell depleted

Bladder Cancer Advocacy Network to Panagiotis Vlachostergios

USD 1,700
2018 - 2018
Project list item
Next generation sequencing to enhance initial staging and dynamically monitor disease response in upper tract urothelial carcinoma

Bladder Cancer Advocacy Network to Philip Hilmi Abbosh, Wafik El-Deiry, Elizabeth Plimack

USD 50,000
2018 - 2020

System

Categories
  • FOR (ANZSRC)

    1116 Medical Physiology

  • RCDC

    Cancer

  • RCDC

    Patient Safety

  • RCDC

    Rare Diseases